Literature DB >> 11528383

Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome.

B Moghadaszadeh1, N Petit, C Jaillard, M Brockington, S Quijano Roy, L Merlini, N Romero, B Estournet, I Desguerre, D Chaigne, F Muntoni, H Topaloglu, P Guicheney.   

Abstract

One form of congenital muscular dystrophy, rigid spine syndrome (MIM 602771), is a rare neuromuscular disorder characterized by early rigidity of the spine and respiratory insufficiency. A locus on 1p35-36 (RSMD1) was recently found to segregate with rigid spine muscular dystrophy 1 (ref. 1). Here we refine the locus and find evidence of linkage disequilibrium associated with SEPN1, which encodes the recently described selenoprotein N (ref. 2). Our identification and analysis of mutations in SEPN1 is the first description of a selenoprotein implicated in a human disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528383     DOI: 10.1038/ng713

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  80 in total

1.  On the road to selenocysteine.

Authors:  Alan M Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

Review 2.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

Review 3.  Selenoproteins and their impact on human health through diverse physiological pathways.

Authors:  Behzad Moghadaszadeh; Alan H Beggs
Journal:  Physiology (Bethesda)       Date:  2006-10

4.  Recoding elements located adjacent to a subset of eukaryal selenocysteine-specifying UGA codons.

Authors:  Michael T Howard; Gaurav Aggarwal; Christine B Anderson; Shikha Khatri; Kevin M Flanigan; John F Atkins
Journal:  EMBO J       Date:  2005-03-24       Impact factor: 11.598

5.  Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies.

Authors:  Christoph Bachmann; Faiza Noreen; Nicol C Voermans; Primo L Schär; John Vissing; Johanna M Fock; Saskia Bulk; Benno Kusters; Steven A Moore; Alan H Beggs; Katherine D Mathews; Megan Meyer; Casie A Genetti; Giovanni Meola; Rosanna Cardani; Emma Mathews; Heinz Jungbluth; Francesco Muntoni; Francesco Zorzato; Susan Treves
Journal:  Hum Mutat       Date:  2019-04-01       Impact factor: 4.878

6.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia.

Authors:  Cristina Dias; Murat Sincan; Praveen F Cherukuri; Rosemarie Rupps; Yan Huang; Hannah Briemberg; Kathryn Selby; James C Mullikin; Thomas C Markello; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

Review 7.  Selenoproteins: molecular pathways and physiological roles.

Authors:  Vyacheslav M Labunskyy; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

8.  Selenoprotein N deficiency in mice is associated with abnormal lung development.

Authors:  Behzad Moghadaszadeh; Branden E Rider; Michael W Lawlor; Martin K Childers; Robert W Grange; Kushagra Gupta; Steve S Boukedes; Caroline A Owen; Alan H Beggs
Journal:  FASEB J       Date:  2013-01-16       Impact factor: 5.191

9.  Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy.

Authors:  Mustafa Nazıroglu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

10.  Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursors.

Authors:  Perrine Castets; Svetlana Maugenre; Corine Gartioux; Mathieu Rederstorff; Alain Krol; Alain Lescure; Shahragim Tajbakhsh; Valérie Allamand; Pascale Guicheney
Journal:  BMC Dev Biol       Date:  2009-08-22       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.